Sökning: "Ida Nielsen"

Hittade 3 avhandlingar innehållade orden Ida Nielsen.

  1. 1. New strategies for characterizing Prussian blue analogues

    Författare :Ida Nielsen; William Robert Brant; Andrew Kentaro Inge; Uppsala universitet; []
    Nyckelord :NATURVETENSKAP; NATURAL SCIENCES; Prussian blue analogues; positron annihilation lifetime spectroscopy; Mössbauer spectroscopy; sodium-ion batteries; neutron diffraction; octahedral tilting; sodium iron hexacyanoferrate; Kemi med inriktning mot materialkemi; Chemistry with specialization in Materials Chemistry;

    Sammanfattning : Prussian blue analogues (PBAs), AxM[M’(CN)6]1–y·zH2O, are used in many different applications, such as energy storage, due to their tunable composition and structural diversity. To understand the material properties, it is important to accurately determine the composition and atomic structure of these materials. LÄS MER

  3. 2. Congestion Charging in Urban Networks : Modelling Issues and Simulated Effects

    Författare :Ida Kristoffersson; Leonid Engelson; Otto Anker Nielsen; KTH; []
    Nyckelord :TEKNIK OCH TEKNOLOGIER; ENGINEERING AND TECHNOLOGY; Transport Modelling; Congestion Charging; Departure Time Choice; Dynamic Traffic Simulation; Welfare Effects; Equity;

    Sammanfattning : One of the major challenges cities face today, in their development towards sustainable urban areas, is the need for an efficient and environmentally friendly transport system. This transport system should manage to tie together the city without strong adverse impact on urban environment, air-quality and climate change. LÄS MER

  4. 3. Pharmacometric Evaluation of Biomarkers to Improve Treatment in Oncology

    Författare :Ida Netterberg; Lena Friberg; Mats Karlsson; Elisabet I. Nielsen; Henrik Lindman; Amit Roy; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Pharmacometrics; Biomarkers; Oncology; Population PKPD Modeling; NONMEM; Farmaceutisk vetenskap; Pharmaceutical Science;

    Sammanfattning : Cancer is a family of many different diseases with substantial heterogeneity also within the same cancer type. In the era of personalized medicine, it is desirable to identify an early response to treatment (i.e., a biomarker) that can predict the long-term outcome with respect to both safety and efficacy. LÄS MER